Search results
Johnson & Johnson ordered to pay $260 million in talc trial - Reuters By Investing.com
Investing.com· 16 hours agoAccording to a report from Reuters on Tuesday, Johnson & Johnson (NYSE:JNJ) must pay $260 million to...
Johnson & Johnson Ordered To Pay $260M In Latest Talc Trial - Johnson & Johnson (NYSE:JNJ)
Benzinga· 24 hours agoA jury has ruled that Johnson & Johnson JNJ must pay $260 million to an Oregon woman who claims to...
J&J (JNJ) to Buy Rights to Novel Atopic Dermatitis Candidate
Zacks via Yahoo Finance· 7 days agoJ&J (JNJ) is set to acquire Yellow Jersey Therapeutics, which holds NM26 rights, from Numab's...
Johnson & Johnson At ASCO Highlights Long Term Data From Multiple Myeloma Drug, Shows Sustained...
Benzinga via Yahoo Finance· 1 day agoMonday, Johnson & Johnson (NYSE:JNJ) announced longer-term data from Phase 1/2 MajesTEC-1 study of...
Johnson & Johnson Data Breach Reported; Possibly Connected to Major Lash Group Data Breach | JD...
JD Supra· 7 days agoOn May 29, 2024, Johnson & Johnson (“JNJ”) filed a notice of data breach with the Attorney General of Texas after discovering that confidential information that had been provided ...
Johnson & Johnson (JNJ) is Attracting Investor Attention: Here is What You Should Know
Zacks via Yahoo Finance· 7 days agoJohnson & Johnson (JNJ) is one of the stocks most watched by Zacks.com visitors lately. So, it might...
Johnson & Johnson (JNJ) Rises As Market Takes a Dip: Key Facts
Zacks via Yahoo Finance· 5 days agoJohnson & Johnson (JNJ) closed the latest trading day at $145.28, indicating a +0.58% change from...
The Potential Rise in the Price of Johnson & Johnson
Knox Daily· 23 hours agoWells Fargo also remained covering JNJ and has decreased its forecast on December 13, 2023 with a “an Equal weight” recommendation from previously “an Overweight” rating.
Johnson & Johnson (NYSE:JNJ) Stock's Been Sliding But Fundamentals Look Decent: Will The Market...
Simply Wall St. via Yahoo Finance· 7 days agoWith its stock down 11% over the past three months, it is easy to disregard Johnson & Johnson (NYSE:...
Pharma Stock Roundup: JNJ, MRK M&A Deals, SNY, RHHBY Drugs' Priority Review & More
Zacks via Yahoo Finance· 5 days agoJ&J (JNJ) and Merck (MRK) announce the acquisitions of private biotechs. The FDA grants Priority...